AI-generated analysis. Always verify with the original filing.
Bioxytran, Inc. entered into a commercial Distribution Agreement on February 10, 2026, with Khoury Medical LTD to commercialize A-SUQAR®, a chewable dietary supplement containing Bioxytran's proprietary partially hydrolyzed guar gum (PHGG) formulation, in permitted markets. The agreement grants distribution rights initially non-exclusive, with potential volume-based exclusivity upon reaching purchase thresholds.
Event Type
Disclosure
Mandatory
Variant
8-K
. Entry into a Material Definitive Agreement. On February 10, 2026, Bioxytran entered into a commercial Distribution Agreement, attached hereto as Exhibit 10.90
. Other Events On February 17, 2026, the Company issued a press-release over Globe Newswire, enclosed hereto as Exhibit 99.1, under the title: Bioxytran, Inc. A
Financial Statements and Exhibits. Exhibit Number Description 10.90* Form of Distribution Agreement with Khoury Medical LTD, dated February 10, 2026. 99.1* Pres
Material Agreement